eHEALTH Bureau
Dr Reddy’s Laboratories has recently announced that it will be launching Lansoprazole delayed-release capsules (15 mg and 30 mg), a bioequivalent generic version of Prevacid Delayed-Release Capsules, in the US market. The Food & Drug Administration (FDA) approved Dr Reddy’s ANDA for Lansoprazole delayed-release capsules on October 15, 2010. Launch preparations are complete and shipments will commence shortly.
Dr Reddy’s Lansoprazole delayed-release capsules are available in bottles of 30 & 90 counts in 15mg and 90 and 500 counts in 30 mg.
Established in 1984, Dr Reddy’s Laboratories is a global pharmaceutical company fulfilling the purpose of providing affordable and innovative medicines through three core businesses: Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. The products are marketed globally, with a focus on India, US, UK, Germany and Russia.
Like
Dislike
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.
